All products and promotions are independently selected by our experts. To help us provide free impartial advice, we will earn an affiliate commission if you buy something. Click here to learn more ...

British device manufacturer Manhattan TV has just become the latest such firm to announce the imminent launch of their next generation IPTV box – the Manhattan Aero, which is another one that includes ...

Smart TV Platform TiVo has secured certification to deploy support for broadband-based live TV streaming service Freely across a new category of streaming-only devices, which could help spread the ...

All products and promotions are independently selected by our experts. To help us provide free impartial advice, we will earn an affiliate commission if you buy something. Click here to learn more ...

The Humax MX7 is an attractive, keenly priced, and excellent choice that not only serves all the needs of today with its smart features and solar integration but is also fully prepared for the future ...

One man's trash is another man's treasure... literally To this end, SuperBin has developed an AI robot that collects circular resources such as recyclable PET bottles and cans. The robot, dubbed ...

Humax has added a host of new pay-as-you-go content to its Aura Freeview Play Recorder via a major firmware update. The update to the on-board Android TV operating system means users can now access ...

The Humax Aura 4K could be the best reason yet to cut ties with your premium pay TV service. It’s powerful, fast and built for binges. Why you can trust T3 Our expert reviewers spend hours testing and ...

Genmab wrapped up an eventful week on Friday as the Danish biotech launched an up to $200 million-per-product cancer therapy collaboration with BliNK Biomedical, and raised $503 million through an ...

GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase 3 trial of cemiplimab, an anti-PD-1, versus investigator's choice (IC) chemotherapy in ≥2 line recurrent or metastatic cervical ...

A phase 1 dose-escalation study of IPH2102 (lirilumab, BMS-986015, LIRI), a fully human anti KIR monoclonal antibody (mAb) in patients (pts) with various hematologic (HEM) or solid malignancies (SOL).